logo
ResearchBunny Logo
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

Medicine and Health

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

R. Grewal, L. Nguyen, et al.

This important study estimated the effectiveness of monovalent mRNA COVID-19 vaccine booster doses against severe outcomes from the Omicron variant in adults aged 50 and older in Ontario. Conducted by a team of experts, it reveals that booster doses provided strong protection against severe outcomes for at least three months, with insights into the waning effect over time and variations across sublineages.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding of the subject.

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Medicine and Health

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants

M. Belik, P. Jalkanen, et al.

Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
Medicine and Health

Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period

P. T. V. Florentino, F. J. O. Alves, et al.

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
Medicine and Health

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma

A. Caputo, F. Nicoli, et al.

Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs
Medicine and Health

Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

R. Capuano, L. Prosperini, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny